UPDATE: Danaher Q4 Revenues Rise 38 Percent on Life Sciences & Diagnostics Growth | GenomeWeb

The story has been updated to include comments made by company executives during a conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today reported a 38 percent increase in its fourth-quarter revenues as its Life Sciences & Diagnostics segment more than doubled its sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.